US EditionPublished • loading... • Updated
LSTA FY2025 EPS Reduced by Brookline Capital Management
Summary by themarketsdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
LSTA FY2025 EPS Reduced by Brookline Capital Management
Lisata Therapeutics, Inc. (NASDAQ:LSTA – Free Report) – Investment analysts at Brookline Capital Management reduced their FY2025 EPS estimates for shares of Lisata Therapeutics in a note issued to investors on Wednesday, January 21st. Brookline Capital Management analyst K. Dolliver now anticipates that the company will earn ($2.46) per share for the year, down from […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
